Sugi Predict

Sugi Predict / Compounds / SCHEMBL824564

SCHEMBL824564

SCHEMBL824564

CNC(=O)Nc1ccccc1F

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.77
▸ NPC1 O15118 6/20 0.77
▸ RAB9A P51151 6/20 0.77
▸ ALDH1A1 P00352 4/20 0.73
▸ RECQL P46063 1/20 0.73
▸ HTT P42858 4/20 0.62
▸ POLB P06746 1/20 0.61
▸ LMNA P02545 2/20 0.60
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ KMT2A Q03164 4/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ MAPT P10636 2/20 0.57
▸ NFKB1 P19838 2/20 0.57
▸ NFKB2 Q00653 2/20 0.57
▸ RELA Q04206 2/20 0.57
▸ TAS1R3 Q7RTX0 1/20 0.57
▸ TAS1R1 Q7RTX1 1/20 0.57
▸ PKM P14618 1/20 0.57
▸ KDM4E B2RXH2 1/20 0.55
▸ GAA P10253 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11202950 0.87 RAB9A (1.00) SMN1; SMN2NPC1RAB9AALDH1A1HTT
SCHEMBL30851501 0.87 RAB9A (1.00) SMN1; SMN2NPC1RAB9AALDH1A1HTT
SCHEMBL14003501 0.85 ALDH1A1 (1.00) SMN1; SMN2NPC1RAB9AALDH1A1RECQL
SCHEMBL31308926 0.85 SMN1; SMN2 (0.62) SMN1; SMN2NPC1RAB9AALDH1A1RECQL
SCHEMBL6851008 0.84 RAB9A (0.64) SMN1; SMN2NPC1RAB9AALDH1A1RECQL
SCHEMBL27467650 0.82 RAB9A (0.80) SMN1; SMN2NPC1RAB9AALDH1A1HTT
SCHEMBL28269889 0.81 NPC1 (0.71) SMN1; SMN2NPC1RAB9AALDH1A1HTT
SCHEMBL3542147 0.80 RAB9A (0.77) SMN1; SMN2NPC1RAB9AALDH1A1HTT
SCHEMBL13628343 0.80 SMN1; SMN2 (0.73) SMN1; SMN2NPC1RAB9AALDH1A1RECQL
SCHEMBL2605749 0.79 KMT2A (0.63) SMN1; SMN2NPC1RAB9AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113923988-B Substituted arylmethyl ureas and heteroarylmethyl ureas, analogs thereof, and methods of using the same 爱彼特生物制药公司 2024-12-13 — — CN disclosed
US-10399933-B2 Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer BRISTOL-MYERS SQUIBB COMPANY (US) 2019-09-03 — — US disclosed
US-10167254-B2 IDO inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2019-01-01 — — US disclosed
US-9944633-B2 Compounds and methods for the treatment of isocitrate dehydrogenase related diseases THE BROAD INSTITUTE, INC. (US) 2018-04-17 — — US disclosed
US-20180072660-A1 INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER BRISTOL MYERS SQUIBB CO (US) 2018-03-15 — — US disclosed
US-9790169-B2 IDO inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2017-10-17 — — US disclosed
US-20170231999-A1 IDO INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-08-17 — — US disclosed
US-20160289171-A1 IDO INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2016-10-06 — — US disclosed
US-20160102087-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF ISOCITRATE DEHYDROGENASE RELATED DISEASES PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2016-04-14 — — US disclosed
US-9120810-B2 Compounds and methods for the treatment of isocitrate dehydrogenase related diseases THE BOARD INSTITUTE, INC. (US) 2015-09-01 — — US disclosed
US-4273572-A HERBICIDES CHEVRON RESEARCH COMPANY (US) 1981-06-16 — — US disclosed
US-4200450-A HERBICIDES CHEVRON RESEARCH COMPANY (US) 1980-04-29 — — US disclosed
US-4159281-A HERBICIDE INTERMEDIATES CHEVRON RESEARCH COMPANY (US) 1979-06-26 — — US disclosed
US-4111683-A HERBICIDE CHEVRON RESEARCH COMPANY (US) 1978-09-05 — — US disclosed
US-4012225-A Herbicidal 1-alkanoyloxy-haloethyl urea CHEVRON RESEARCH COMPANY (US) 1977-03-15 — — US disclosed
US-4007033-A Herbicidal substituted-haloethyl urea CHEVRON RESEARCH COMPANY (US) 1977-02-08 — — US disclosed
US-3997324-A Herbicidal N- oxythio-substituted ureas CHEVRON RESEARCH COMPANY (US) 1976-12-14 — — US disclosed
US-3978123-A HERBICIDAL N-ALKYLSULFOXYMETHYL-AND-N-ALKYLSULFONYL-METHYL-N-ARYL CHEVRON RESEARCH COMPANY (US) 1976-08-31 — — US disclosed
US-3960943-A HERBICIDES CHEVRON RESEARCH COMPANY (US) 1976-06-01 — — US disclosed
US-3946062-A Preparation of 2-chlorocycloalkylthio urea compounds CHEVRON RESEARCH COMPANY (US) 1976-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10167254-B2 IDO inhibitors IDO1, IDO2, INMT SMN1; SMN2 4280/4885NPC1 2825/4885RAB9A 3625/4885
US-20160102087-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF ISOCITRATE DEHYDROGENASE RELATED DISEASES IDH1, IDH2, IDH3A SMN1; SMN2 1093/4885NPC1 515/4885RAB9A 3444/4885
US-20170231999-A1 IDO INHIBITORS IDO1, IDO2, INMT SMN1; SMN2 4280/4885NPC1 2825/4885RAB9A 3625/4885
US-20180072660-A1 INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER IDO1, IDO2, INMT SMN1; SMN2 4521/4885NPC1 2350/4885RAB9A 3832/4885
US-10399933-B2 Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer IDO1, IDO2, INMT SMN1; SMN2 4521/4885NPC1 2350/4885RAB9A 3832/4885
US-20160289171-A1 IDO INHIBITORS IDO1, IDO2, INMT SMN1; SMN2 4280/4885NPC1 2825/4885RAB9A 3625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.